Atossa Therapeutics Inc (NASDAQ:ATOS)
| 2.46 Delayed Data As of May 12 |  -0.16 / -6.11%Today’s Change | 0.81 Today|||52-Week Range 5.08 | +158.95% Year-to-Date |
Latest ATOS News | Press Releases
No recent news for Atossa Therapeutics Inc.
Today’s Trading
| Previous close | 2.62 |
| Today’s open | 2.59 |
| Day’s range | 2.44 - 2.78 |
| Volume | 9,152,399 |
| Average volume (3 months) | 19,843,580 |
| Market cap | $331.1M |
Data as of 3:59pm ET, 05/12/2021
Growth & Valuation
| Earnings growth (last year) | +2.67% |
| Earnings growth (this year) | +92.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IBIOIbio Inc | -0.00 | -0.34% |
| NATRNatures Sunshine Pro... | -0.64 | -3.32% |
| ---- | ||
| CDXCChromadex Corp | -0.16 | -2.26% |
Data as of 7:39pm ET, 05/12/2021
Financials
| Next reporting date | May 18, 2021 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$17.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
